IBDEI07G ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9760,1,4,0)
 ;;=4^365.89
 ;;^UTILITY(U,$J,358.3,9760,2)
 ;;=^88069
 ;;^UTILITY(U,$J,358.3,9761,0)
 ;;=365.05^^63^616^38
 ;;^UTILITY(U,$J,358.3,9761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9761,1,3,0)
 ;;=3^Opn Ang w/ brdrlne fnd-Hi Risk
 ;;^UTILITY(U,$J,358.3,9761,1,4,0)
 ;;=4^365.05
 ;;^UTILITY(U,$J,358.3,9761,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,9762,0)
 ;;=365.06^^63^616^40
 ;;^UTILITY(U,$J,358.3,9762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9762,1,3,0)
 ;;=3^Prim Ang Clos w/o Glauc Dmg
 ;;^UTILITY(U,$J,358.3,9762,1,4,0)
 ;;=4^365.06
 ;;^UTILITY(U,$J,358.3,9762,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,9763,0)
 ;;=365.70^^63^616^31
 ;;^UTILITY(U,$J,358.3,9763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9763,1,3,0)
 ;;=3^Glaucoma,Stage NOS
 ;;^UTILITY(U,$J,358.3,9763,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,9763,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,9764,0)
 ;;=365.71^^63^616^17
 ;;^UTILITY(U,$J,358.3,9764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9764,1,3,0)
 ;;=3^Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,9764,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,9764,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,9765,0)
 ;;=365.72^^63^616^18
 ;;^UTILITY(U,$J,358.3,9765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9765,1,3,0)
 ;;=3^Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,9765,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,9765,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,9766,0)
 ;;=365.73^^63^616^30
 ;;^UTILITY(U,$J,358.3,9766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9766,1,3,0)
 ;;=3^Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,9766,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,9766,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,9767,0)
 ;;=365.74^^63^616^14
 ;;^UTILITY(U,$J,358.3,9767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9767,1,3,0)
 ;;=3^Glaucoma,Indeterm Stage
 ;;^UTILITY(U,$J,358.3,9767,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,9767,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,9768,0)
 ;;=V19.11^^63^616^5
 ;;^UTILITY(U,$J,358.3,9768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9768,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,9768,1,4,0)
 ;;=4^V19.11
 ;;^UTILITY(U,$J,358.3,9768,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,9769,0)
 ;;=V19.19^^63^616^6
 ;;^UTILITY(U,$J,358.3,9769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9769,1,3,0)
 ;;=3^Family Hx Oth Spec Eye Disord
 ;;^UTILITY(U,$J,358.3,9769,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,9769,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,9770,0)
 ;;=365.62^^63^616^8
 ;;^UTILITY(U,$J,358.3,9770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9770,1,3,0)
 ;;=3^Glauc Assoc w/ Ocular Inflamm
 ;;^UTILITY(U,$J,358.3,9770,1,4,0)
 ;;=4^365.62
 ;;^UTILITY(U,$J,358.3,9770,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,9771,0)
 ;;=365.00^^63^616^33
 ;;^UTILITY(U,$J,358.3,9771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9771,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,9771,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,9771,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,9772,0)
 ;;=365.60^^63^616^10
 ;;^UTILITY(U,$J,358.3,9772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9772,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,9772,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,9772,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,9773,0)
 ;;=365.9^^63^616^35
 ;;^UTILITY(U,$J,358.3,9773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9773,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,9773,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,9773,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,9774,0)
 ;;=365.22^^63^616^12
 ;;^UTILITY(U,$J,358.3,9774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9774,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,9774,1,4,0)
 ;;=4^365.22
 ;;^UTILITY(U,$J,358.3,9774,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,9775,0)
 ;;=365.59^^63^616^7
 ;;^UTILITY(U,$J,358.3,9775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9775,1,3,0)
 ;;=3^Glauc Assoc w/ Lens D/O
 ;;^UTILITY(U,$J,358.3,9775,1,4,0)
 ;;=4^365.59
 ;;^UTILITY(U,$J,358.3,9775,2)
 ;;=^268773
 ;;^UTILITY(U,$J,358.3,9776,0)
 ;;=365.44^^63^616^9
 ;;^UTILITY(U,$J,358.3,9776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9776,1,3,0)
 ;;=3^Glauc Assoc w/ Systemic Syndromes
 ;;^UTILITY(U,$J,358.3,9776,1,4,0)
 ;;=4^365.44
 ;;^UTILITY(U,$J,358.3,9776,2)
 ;;=^268769
 ;;^UTILITY(U,$J,358.3,9777,0)
 ;;=377.14^^63^616^36
 ;;^UTILITY(U,$J,358.3,9777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9777,1,3,0)
 ;;=3^Glaucomatous Atrophy
 ;;^UTILITY(U,$J,358.3,9777,1,4,0)
 ;;=4^377.14
 ;;^UTILITY(U,$J,358.3,9777,2)
 ;;=^269218
 ;;^UTILITY(U,$J,358.3,9778,0)
 ;;=365.14^^63^616^15
 ;;^UTILITY(U,$J,358.3,9778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9778,1,3,0)
 ;;=3^Glaucoma,Infantile/Juv
 ;;^UTILITY(U,$J,358.3,9778,1,4,0)
 ;;=4^365.14
 ;;^UTILITY(U,$J,358.3,9778,2)
 ;;=^268750
 ;;^UTILITY(U,$J,358.3,9779,0)
 ;;=743.20^^63^616^3
 ;;^UTILITY(U,$J,358.3,9779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9779,1,3,0)
 ;;=3^Buphthalmous,Unsp w/ Oth Ocu Abnormal
 ;;^UTILITY(U,$J,358.3,9779,1,4,0)
 ;;=4^743.20
 ;;^UTILITY(U,$J,358.3,9779,2)
 ;;=^59682
 ;;^UTILITY(U,$J,358.3,9780,0)
 ;;=378.83^^63^617^3
 ;;^UTILITY(U,$J,358.3,9780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9780,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,9780,1,4,0)
 ;;=4^378.83
 ;;^UTILITY(U,$J,358.3,9780,2)
 ;;=Convergence Insufficiency^269277
 ;;^UTILITY(U,$J,358.3,9781,0)
 ;;=378.00^^63^617^5
 ;;^UTILITY(U,$J,358.3,9781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9781,1,3,0)
 ;;=3^Esotropia
 ;;^UTILITY(U,$J,358.3,9781,1,4,0)
 ;;=4^378.00
 ;;^UTILITY(U,$J,358.3,9781,2)
 ;;=Esotropia^42597
 ;;^UTILITY(U,$J,358.3,9782,0)
 ;;=378.10^^63^617^9
 ;;^UTILITY(U,$J,358.3,9782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9782,1,3,0)
 ;;=3^Exotropia
 ;;^UTILITY(U,$J,358.3,9782,1,4,0)
 ;;=4^378.10
 ;;^UTILITY(U,$J,358.3,9782,2)
 ;;=Exotropia^43741
 ;;^UTILITY(U,$J,358.3,9783,0)
 ;;=378.41^^63^617^4
 ;;^UTILITY(U,$J,358.3,9783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9783,1,3,0)
 ;;=3^Esophoria
 ;;^UTILITY(U,$J,358.3,9783,1,4,0)
 ;;=4^378.41
 ;;^UTILITY(U,$J,358.3,9783,2)
 ;;=Esophoria^265435
 ;;^UTILITY(U,$J,358.3,9784,0)
 ;;=378.42^^63^617^8
 ;;^UTILITY(U,$J,358.3,9784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9784,1,3,0)
 ;;=3^Exophoria
 ;;^UTILITY(U,$J,358.3,9784,1,4,0)
 ;;=4^378.42
 ;;^UTILITY(U,$J,358.3,9784,2)
 ;;=Exophoria^265436
 ;;^UTILITY(U,$J,358.3,9785,0)
 ;;=378.50^^63^617^26
 ;;^UTILITY(U,$J,358.3,9785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9785,1,3,0)
 ;;=3^Strabismus,Paralytic
 ;;^UTILITY(U,$J,358.3,9785,1,4,0)
 ;;=4^378.50
 ;;^UTILITY(U,$J,358.3,9785,2)
 ;;=Strabismus, Paralytic^265442
 ;;^UTILITY(U,$J,358.3,9786,0)
 ;;=378.40^^63^617^12
 ;;^UTILITY(U,$J,358.3,9786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9786,1,3,0)
 ;;=3^Heterophoria
 ;;^UTILITY(U,$J,358.3,9786,1,4,0)
 ;;=4^378.40
 ;;^UTILITY(U,$J,358.3,9786,2)
 ;;=Heterophoria^265433
 ;;^UTILITY(U,$J,358.3,9787,0)
 ;;=378.30^^63^617^13
 ;;^UTILITY(U,$J,358.3,9787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9787,1,3,0)
 ;;=3^Heterotropia
 ;;^UTILITY(U,$J,358.3,9787,1,4,0)
 ;;=4^378.30
 ;;^UTILITY(U,$J,358.3,9787,2)
 ;;=Heterotropia^265406
 ;;^UTILITY(U,$J,358.3,9788,0)
 ;;=378.9^^63^617^27
 ;;^UTILITY(U,$J,358.3,9788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9788,1,3,0)
 ;;=3^Strabismus,Unspecified
 ;;^UTILITY(U,$J,358.3,9788,1,4,0)
 ;;=4^378.9
 ;;^UTILITY(U,$J,358.3,9788,2)
 ;;=Ophthalmoplegia, Unspec^123833
 ;;^UTILITY(U,$J,358.3,9789,0)
 ;;=368.00^^63^617^1
 ;;^UTILITY(U,$J,358.3,9789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9789,1,3,0)
 ;;=3^Amblyopia
 ;;^UTILITY(U,$J,358.3,9789,1,4,0)
 ;;=4^368.00
 ;;^UTILITY(U,$J,358.3,9789,2)
 ;;=^5731
 ;;^UTILITY(U,$J,358.3,9790,0)
 ;;=378.73^^63^617^20
 ;;^UTILITY(U,$J,358.3,9790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9790,1,3,0)
 ;;=3^Ocular Myasthenia Gravis
 ;;^UTILITY(U,$J,358.3,9790,1,4,0)
 ;;=4^378.73
 ;;^UTILITY(U,$J,358.3,9790,2)
 ;;=Ocular Myasthenia Gravis^269274
 ;;^UTILITY(U,$J,358.3,9791,0)
 ;;=951.2^^63^617^2
 ;;^UTILITY(U,$J,358.3,9791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9791,1,3,0)
 ;;=3^CN Injury,Fifth
 ;;^UTILITY(U,$J,358.3,9791,1,4,0)
 ;;=4^951.2
 ;;^UTILITY(U,$J,358.3,9791,2)
 ;;=^275898
 ;;^UTILITY(U,$J,358.3,9792,0)
 ;;=378.05^^63^617^6
 ;;^UTILITY(U,$J,358.3,9792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9792,1,3,0)
 ;;=3^Esotropia,Alternating
 ;;^UTILITY(U,$J,358.3,9792,1,4,0)
 ;;=4^378.05
 ;;^UTILITY(U,$J,358.3,9792,2)
 ;;=^265411
 ;;^UTILITY(U,$J,358.3,9793,0)
 ;;=378.01^^63^617^7
 ;;^UTILITY(U,$J,358.3,9793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9793,1,3,0)
 ;;=3^Esotropia,Monocular
 ;;^UTILITY(U,$J,358.3,9793,1,4,0)
 ;;=4^378.01
 ;;^UTILITY(U,$J,358.3,9793,2)
 ;;=^265409
 ;;^UTILITY(U,$J,358.3,9794,0)
 ;;=378.32^^63^617^14
 ;;^UTILITY(U,$J,358.3,9794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9794,1,3,0)
 ;;=3^Hypotropia
 ;;^UTILITY(U,$J,358.3,9794,1,4,0)
 ;;=4^378.32
 ;;^UTILITY(U,$J,358.3,9794,2)
 ;;=^265417
 ;;^UTILITY(U,$J,358.3,9795,0)
 ;;=378.63^^63^617^15
 ;;^UTILITY(U,$J,358.3,9795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9795,1,3,0)
 ;;=3^Limited Duction,Oth Condition
 ;;^UTILITY(U,$J,358.3,9795,1,4,0)
 ;;=4^378.63
 ;;^UTILITY(U,$J,358.3,9795,2)
 ;;=^269273
 ;;^UTILITY(U,$J,358.3,9796,0)
 ;;=378.52^^63^617^19
 ;;^UTILITY(U,$J,358.3,9796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9796,1,3,0)
 ;;=3^Nerve Palsy,Third
 ;;^UTILITY(U,$J,358.3,9796,1,4,0)
 ;;=4^378.52
 ;;^UTILITY(U,$J,358.3,9796,2)
 ;;=^269268
 ;;^UTILITY(U,$J,358.3,9797,0)
 ;;=378.72^^63^617^21
 ;;^UTILITY(U,$J,358.3,9797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9797,1,3,0)
 ;;=3^Ophthalmoplegia External Progressive
 ;;^UTILITY(U,$J,358.3,9797,1,4,0)
 ;;=4^378.72
 ;;^UTILITY(U,$J,358.3,9797,2)
 ;;=^265211
 ;;^UTILITY(U,$J,358.3,9798,0)
 ;;=378.55^^63^617^22
 ;;^UTILITY(U,$J,358.3,9798,1,0)
 ;;=^358.31IA^4^2
